JEFFS ROGER 4
4 · Axsome Therapeutics, Inc. · Filed Sep 2, 2025
Insider Transaction Report
Form 4
JEFFS ROGER
Director
Transactions
- Sale
Common Stock
2025-09-02$123.68/sh−13,464$1,665,228→ 57,510 total
Footnotes (3)
- [F1]Represents the sale of underlying shares of previously exercised stock options.
- [F2]Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed.
- [F3]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $121.30 and $124.60.